Post Marketing Information DHCPL 23/07/2019 Risk of non-melanoma skin cancer associated with use of hydrochlorothiazide DHCPL 03/12/2018 Hydrochlorothiazide: Association with non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma) [Sanofi] DHCPL 21/11/2018 Hydrochlorothiazide: Increased risk of non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma) DHCPL 14/11/2018 Hydrochlorothiazide: Association with non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Tablet, Film Coated, Amlodipine 10 mg + Hydrochlorothiazide 12.5 mg + Valsartan 160 mg National Heart Centre
ORAL Select a brand starting with the letter: E EXFORGE HCT TABLET 10MG/160MG/12.5MG [SIN13899P] EXFORGE HCT TABLET 5MG/160MG/12.5MG [SIN13901P]